Related Experiment Video
Updated: Feb 10, 2026

Evaluating the Effect of Pesticides on the Larvae of the Solitary Bees
Published on: October 15, 2021
Pesticides and human cancers
Michael C R Alavanja1, Matthew R Bonner
1Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD, USA. alavanjm@mail.nih.gov
The carcinogenicity of many pesticides is poorly understood. Future research needs better exposure assessment and interdisciplinary collaboration between toxicologists and epidemiologists for improved human health risk evaluation.
Area of Science:
- Environmental Toxicology
- Epidemiology
- Carcinogenesis
Background:
- The human carcinogenicity of most pesticides remains poorly evaluated and understood.
- Current understanding of pesticide risks is limited by inadequate mechanistic data.
Purpose of the Study:
- To highlight the need for improved mechanistic data generation in animal studies and epidemiology.
- To emphasize the necessity of enhanced exposure assessment in large prospective studies.
- To advocate for increased multidisciplinary collaboration between toxicologists and epidemiologists.
Main Methods:
- Review of current knowledge gaps in pesticide carcinogenicity.
- Identification of key areas for future research, including mechanistic studies and exposure assessment.
- Promotion of collaborative research frameworks, particularly molecular epidemiology.
Main Results:
- Mechanistic data from animal and human studies are crucial for understanding pesticide carcinogenicity.
- Accurate exposure assessment in large prospective studies is essential for reliable exposure-response data.
- Multidisciplinary collaborations, especially in molecular epidemiology, offer significant opportunities for advancement.
Conclusions:
- Addressing the human carcinogenicity of pesticides requires a concerted effort combining toxicology and epidemiology.
- Future research must prioritize robust exposure assessment and mechanistic investigations.
- Fostering collaboration between toxicologists and epidemiologists is key to advancing the field and protecting public health.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

